4//SEC Filing
REXAHN PHARMACEUTICALS, INC. 4
Accession 0001140361-14-002177
$IRDCIK 0001228627operating
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 7:28 PM ET
Size
10.3 KB
Accession
0001140361-14-002177
Insider Transaction Report
Form 4
Jeong Tae Heum
DirectorCFO
Transactions
- Award
Stock Option (right to purchase)
2014-01-12+175,000→ 175,000 totalExercise: $1.14Exp: 2024-01-12→ Common Stock (175,000 underlying)
Holdings
- 505,000
Common Stock
- 250,000
Stock Option (right to purchase)
Exercise: $0.31Exp: 2023-03-01→ Common Stock (250,000 underlying) - 250,000
Stock Option (right to purchase)
Exercise: $0.78Exp: 2018-12-11→ Common Stock (250,000 underlying) - 500,000
Stock Option (right to purchase)
Exercise: $0.80Exp: 2015-01-20→ Common Stock (500,000 underlying)
Footnotes (4)
- [F1]Options will vest and be exercisable based on the following schedule: 52,500 on January 12, 2015, 52,500 on January 12, 2016, and 70,000 on January 12, 2017.
- [F2]Options will vest and be exercisable based on the following schedule: 75,000 on March 1, 2014, 75,000 on March 1, 2015, and 100,000 on March 1, 2016.
- [F3]Options vested and became exercisable based on the following schedule 75,000 on December 11, 2009, 75,000 on December 11, 2010, and 100,000 on December 11, 2011.
- [F4]Options vested and became exercisable based on the following schedule 150,000 on January 20, 2006, 150,000 on January 20, 2007, and 200,000 on January 20, 2008.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001228627
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 7:28 PM ET
- Size
- 10.3 KB